788 filings
Page 5 of 40
6-K
qwprfte jjoq
6 Jul 22
Aeterna Zentaris Announces Further Adjournment of Shareholder Meeting
4:05pm
6-K
knir1rlhj3 de
21 Jun 22
Aeterna Zentaris Announces Results of Annual Meeting of Shareholders
4:12pm
6-K
m2bnqzwnm0uf6fjua
21 Jun 22
Report of Voting Results
4:04pm
6-K
hwsj9sy3ce8
31 May 22
Annual General and Special Meeting of Shareholders
6:12am
EFFECT
mb0f4b
20 May 22
Notice of effectiveness
12:15am
EFFECT
mx1w2m
20 May 22
Notice of effectiveness
12:15am
EFFECT
7uljet5i03ldra g50vw
20 May 22
Notice of effectiveness
12:15am
6-K
433rv
17 May 22
Current report (foreign)
3:04pm
6-K
1dltf 5pam12boxseg
16 May 22
Aeterna Zentaris Announces Virtual 2022 Meeting of Shareholders and Urges Shareholders to Vote in Favor of the Proposed Share Consolidation
2:14pm
POS AM
g5jhveja
12 May 22
Prospectus update (post-effective amendment)
6:34pm
POS AM
3kyt3
12 May 22
Prospectus update (post-effective amendment)
6:31pm
POS AM
2etjs
12 May 22
Prospectus update (post-effective amendment)
6:28pm
6-K
3a3 6anpz
11 May 22
Aeterna Zentaris Reports First Quarter 2022 Financial Results and Provides Business Outlook
7:48pm
6-K
ricxbjpqas86e
10 May 22
Current report (foreign)
7:18pm
6-K
4frgrz lnub152digdsz
19 Apr 22
Aeterna Zentaris Secures New European Patent Related to Use of Macimorelin for the Diagnosis of Growth Hormone Deficiency in Adults
8:45pm
6-K/A
wn2b ysxfidcsvh
31 Mar 22
Consolidated Financial Statements
4:05pm
6-K
diubw4 fi8ygw4o3wa8
29 Mar 22
Aeterna Zentaris Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Outlook
8:10am
6-K
4i6oo
28 Mar 22
Consolidated Financial Statements
9:35pm
6-K
573ku
10 Mar 22
Current report (foreign)
6:21pm